Article
Mechanisms of tigecycline resistance in the Enterobacteriaceae and Acinetobacter baumannii
2011-01-01
Abstract excerpt
Tigecycline is the first glycylcycline to enter clinical use and displays good in vitro activity against a broad range of Gram-positive and Gram-negative pathogens. It is often used as an agent of last resort for the treatment of infections caused by multidrug-resistant Gram-negative bacteria including some Enterobacteriaceae species and Acinetobacter baumannii. Therefore, the recent emergence of tigecycline resis...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1b0b1756-fc9f-5af9-a440-a9c148a56117
- DOI
- 10.21954/ou.ro.0000ee3b
